FDA inspection

Seres Therapeutics, Inc.: FDA inspection ending Dec 9, 2022

FDA inspection 1202242 · Waltham, MA

Key facts

Inspection ID 1202242
Firm Seres Therapeutics, Inc.
FEI number 3021578714
Address 9 4th Ave
City Waltham
State MA
ZIP 02451-7506
Fiscal year 2023
Inspection end date Dec 9, 2022
Project area Vaccine, Allergenic, and Live Biotherapeutic Products
Product type Biologics, Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections